Vesicles as a tool for transdermal and dermal delivery.

Transdermal and dermal drug delivery is problematic because the skin, as a natural barrier, has a very low permeation rate. Therefore several methods have been assessed to increase this rate locally and temporarily. One approach is the use of vesicle formulations. In this paper the effectiveness of conventional and deformable vesicles as drug delivery systems as well as their possible mode of action as permeation enhancers or transdermal drug carriers will be discussed.:

[1]  A. Schätzlein,et al.  Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo , 1997 .

[2]  D. Downing,et al.  Interaction between corneocytes and stratum corneum lipid liposomes in vitro. , 1990, Biochimica et biophysica acta.

[3]  H. Junginger,et al.  Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X‐ray scattering studies , 1995, The British journal of dermatology.

[4]  H. Junginger,et al.  Transdermal Delivery of Pergolide from Surfactant-Based Elastic and Rigid Vesicles: Characterization and in Vitro Transport Studies , 2002, Pharmaceutical Research.

[5]  E. Peira,et al.  Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. , 2002, International journal of pharmaceutics.

[6]  W. Wohlrab,et al.  Penetration kinetics of liposomal hydrocortisone in human skin. , 1987, Dermatologica.

[7]  A. Dobs,et al.  Transdermal testosterone. Viewpoints , 1998 .

[8]  A. Parrott.  Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning. , 1989, Aviation, space, and environmental medicine.

[9]  F. Bonte,et al.  Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. , 1993, Journal of pharmaceutical sciences.

[10]  J. Bouwstra,et al.  Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature. , 1999, The Journal of investigative dermatology.

[11]  P. Elias,et al.  The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. , 1987, Critical reviews in therapeutic drug carrier systems.

[12]  G. Cevc,et al.  Transdermal immunization with large proteins by means of ultradeformable drug carriers , 1995, European journal of immunology.

[13]  M. Hashida,et al.  Preservative activity and in vivo percutaneous penetration of butylparaben entrapped in liposomes. , 1986, Chemical & pharmaceutical bulletin.

[14]  K. Goa,et al.  Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use. , 1990, Drugs.

[15]  J. Kreuter,et al.  Colloidal Drug Delivery Systems , 1994 .

[16]  D. Downing,et al.  Lipid organization in pig stratum corneum. , 1995, Journal of lipid research.

[17]  H. Junginger,et al.  Interactions between liposomes and human skin in vitro, a confocal laser scanning microscopy study. , 1998, Biochimica et biophysica acta.

[18]  W. Wohlrab,et al.  The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. , 1989, Dermatologische Monatschrift.

[19]  M. Fresta,et al.  Corticosteroid dermal delivery with skin-lipid liposomes , 1997 .

[20]  T. Redelmeier,et al.  Skin Barrier: Principles of Percutaneous Absorption , 1996 .

[21]  E. Nieschlag,et al.  TRANSDERMAL TESTOSTERONE , 1989, The Lancet.

[22]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[23]  H. Junginger,et al.  Estradiol Permeation from Nonionic Surfactant Vesicles Through Human Stratum Corneum in Vitro , 1994, Pharmaceutical Research.

[24]  G. E. El Maghraby,et al.  Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.

[25]  B. W. Barry,et al.  Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  A. Kolpakova,et al.  [The skin barrier]. , 1972, Vestnik dermatologii i venerologii.

[27]  H. Junginger,et al.  The effect of surfactant-based elastic and rigid vesicles on the penetration of lidocaine across human skin , 2002 .

[28]  M. Hashida,et al.  Percutaneous absorption of butylparaben from liposomes in vitro. , 1986, Chemical & pharmaceutical bulletin.

[29]  A. Schätzlein,et al.  TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .

[30]  Adrian C. Williams,et al.  Skin delivery of 5‐fluorouracil from ultradeformable and standard liposomes in‐vitro , 2001, The Journal of pharmacy and pharmacology.

[31]  Adrian C. Williams,et al.  Skin Delivery of Oestradiol from Deformable and Traditiona Liposomes: Mechanistic Studies , 1999, The Journal of pharmacy and pharmacology.

[32]  N. Yata,et al.  Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes. , 1999, Journal of drug targeting.

[33]  P. Elias,et al.  Epidermal lipids, barrier function, and desquamation. , 1983, The Journal of investigative dermatology.

[34]  J. Bouwstra,et al.  The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[35]  J. Bouwstra,et al.  Skin Penetration and Mechanisms of Action in the Delivery of the D2-Agonist Rotigotine from Surfactant-Based Elastic Vesicle Formulations , 2003, Pharmaceutical Research.

[36]  M. Mezei,et al.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.

[37]  Geoffrey Lee.  Prediction of Percutaneous Penetration , 1997 .

[38]  M. Iwaki,et al.  Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. , 1996, Journal of pharmaceutical sciences.

[39]  Andreas G. Schätzlein,et al.  Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. , 1998, Biochimica et biophysica acta.

[40]  N. Weiner,et al.  The influence of particle size of liposomes on the deposition of drug into skin , 1994 .

[41]  R. Guy,et al.  Controlled drug release from a novel liposomal delivery system. I. Investigation of transdermal potential , 1987 .

[42]  Williams Ml,et al.  The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. , 1987 .

[43]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[44]  E. Touitou,et al.  Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.

[45]  L. Wiseman,et al.  Transdermal Estradiol/Norethisterone , 1994 .

[46]  L. Coderch,et al.  Influence of the Fluidity of Liposome Compositions on Percutaneous Absorption , 2000, Drug delivery.

[47]  N. Weiner,et al.  Mechanisms of topical delivery of liposomally entrapped drugs , 1985 .

[48]  P. Wertz,et al.  Elasticity of vesicles affects hairless mouse skin structure and permeability. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[49]  The Lipid Organisation of the Skin Barrier: Liquid and Crystalline Domains Coexist in Lamellar Phases , 2002, Journal of biological physics.

[50]  A. Florence,et al.  Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. , 1993, Drugs.

[51]  H. Schaefer,et al.  Principles of Percutaneous Absorption , 1980 .

[52]  J. Bouwstra,et al.  The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. , 2002, Biochimica et biophysica acta.

[53]  M. Foldvari,et al.  Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. , 1990, Journal of microencapsulation.

[54]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[55]  R. Scheuplein,et al.  TKANSPORT INTO AND WITHIN THE SKIN , 1969 .

[56]  J. Bouwstra,et al.  Structure of the skin barrier and its modulation by vesicular formulations. , 2003, Progress in lipid research.

[57]  Q. Ping,et al.  Lecithin vesicular carriers for transdermal delivery of cyclosporin A. , 2000, International journal of pharmaceutics.

[58]  J. Fonollosa,et al.  Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[59]  Q. Ping,et al.  Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. , 2000, Drug delivery.

[60]  P. Wertz,et al.  Lipids and barrier function of the skin. , 2000, Acta dermato-venereologica. Supplementum.

[61]  N. Weiner,et al.  Topical delivery of ciclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. , 1990, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[62]  N. Weiner,et al.  Influence of liposomal drug entrapment on percutaneous absorption , 1984 .

[63]  M. Mezei,et al.  Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.

[64]  R. Scheuplein,et al.  Permeability of the skin. , 1971, Physiological reviews.

[65]  R. Guy,et al.  Controlled drug release from a novel liposomal delivery system. II. Transdermal delivery characteristics , 1990 .

[66]  G. Cevc.  Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. , 1996, Critical reviews in therapeutic drug carrier systems.

[67]  J. Bouwstra,et al.  Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. , 2004, The Journal of investigative dermatology.

[68]  Y. Chien,et al.  The nicotine transdermal system. , 1998, Clinics in dermatology.

[69]  J. Bouwstra,et al.  Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery , 1994 .

[70]  J. Bouwstra,et al.  The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[71]  C. Shim,et al.  Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel , 1997 .

[72]  Cevc,et al.  Non‐uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high‐resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes) , 1998, The British journal of dermatology.

[73]  G. E. El Maghraby,et al.  Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. , 2000, International journal of pharmaceutics.

[74]  G. Cevc,et al.  New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. , 2001, Biochimica et biophysica acta.

[75]  J. Dubois,et al.  Percutaneous absorption of a new antiandrogen included in liposomes or in solution , 1995 .

[76]  H. Junginger,et al.  Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. , 1999, Biochimica et biophysica acta.

[77]  H. Junginger,et al.  Interactions Between non-ionic Surfactant Vesicles and human stratum corneum in vitro. , 1995 .

[78]  A. Lloyd,et al.  Basic Principles of Liposomes for Drug Use , 1992 .

[79]  H E Junginger,et al.  Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[80]  S. Zellmer,et al.  Interaction of phosphatidylcholine liposomes with the human stratum corneum. , 1995, Biochimica et biophysica acta.

[81]  G. Cevc,et al.  Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. , 1998, Vaccine.

[82]  J. Burris.  The USA experience with the clonidine transdermal therapeutic system , 1993, Clinical Autonomic Research.

[83]  M. Fresta,et al.  Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles. , 1996, Journal of drug targeting.

[84]  A. Schätzlein,et al.  Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. , 2002, Biochimica et biophysica acta.

[85]  L. Wiseman,et al.  Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women. , 1994, Drugs & Aging.

[86]  A. Wagstaff,et al.  Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. , 2001, Drugs.